The Market Reports

Synopsis
The global market for Hazardous Drugs Closed System Transfer Device was estimated to be worth US$ 957 million in 2024 and is forecast to a readjusted size of US$ 3081 million by 2031 with a CAGR of 18.1% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Hazardous Drugs Closed System Transfer Device cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Hazardous Drugs Closed System Transfer Device is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.
The rapid development of the closed-system drug transfer device market is driven by several key factors. First, there is a growing global emphasis on medical safety and sterile operations, particularly in hospitals, clinics, and other healthcare facilities. Preventing drug contamination and cross-infection has become a top priority. Closed-system drug transfer devices effectively ensure sterility during the transportation and transfer of drugs, reducing the risk of exposure to harmful substances for both healthcare workers and patients.
Second, advancements in biopharmaceuticals and personalized medicine have led to an increase in new types of drugs (such as cancer drugs and immunotherapy agents) that require highly controlled storage and transport conditions. These drugs are often highly active and sensitive, necessitating handling in controlled environments to ensure their stability and efficacy. Additionally, increasingly stringent regulations are compelling healthcare institutions to adopt more advanced transfer systems to comply with standards and guidelines, thereby avoiding potential legal risks and penalties.
In the future, the closed-system drug transfer device market will exhibit several significant trends. On one hand, technological innovation will continue to propel this field forward. For instance, the application of intelligent and automated technologies will make transfer devices more efficient, precise, and easier to manage, reducing the likelihood of human error. The integration of Internet of Things (IoT) technology allows these devices to monitor the status and environmental parameters of drugs in real-time, providing immediate feedback and alerts, which enhances supply chain transparency and traceability.
On the other hand, influenced by concepts of environmental protection and sustainability, manufacturers will place greater emphasis on the environmental performance and energy efficiency of their products. They will develop materials and technologies that are lighter, more energy-efficient, and easier to recycle. Furthermore, as the uneven distribution of global healthcare resources becomes more pronounced, the growing demand for telemedicine services will drive the use of closed-system drug transfer devices in remote areas and primary healthcare facilities, further expanding market coverage.
This report aims to provide a comprehensive presentation of the global market for Hazardous Drugs Closed System Transfer Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hazardous Drugs Closed System Transfer Device by region & country, by Type, and by Application.
The Hazardous Drugs Closed System Transfer Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hazardous Drugs Closed System Transfer Device.
Market Segmentation
By Company
BD Medical, Inc
Equashield
ICU Medical
Simplivia Healthcare Ltd.
Corvida Medical
B. Braun
Yukon Medical
JMS
Caragen Ltd.
Epic Medical
Segment by Type
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hazardous Drugs Closed System Transfer Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hazardous Drugs Closed System Transfer Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hazardous Drugs Closed System Transfer Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index